ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wandschneider, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wandschneider, W.
Related Collections
Right arrow Cerebral protection
Right arrowRelated Article

Ann Thorac Surg 2001;71:2085-2086
© 2001 The Society of Thoracic Surgeons

Correspondence

S100 release as an indicator of cerebral damage: Reply

Wolfgang Wandschneider, MDa

a Department of Cardiovascular Surgery, General Hospital Klagenfurt, St. Veiter Straße 47, A-9020 Klagenfurt, Austria

To the Editor

I thank Dr Whitaker very much for his detailed comments to our paper. However, I cannot agree with all his statements: S100-protein is a long-known specific marker for cerebral injury and is widely used in neurology and traumatology [1].

Doctor Whitaker is right in stating that thymic cells also contain S100 protein. As the mean age in our patient groups was 65 years it is unlikely that any vital thymic tissue was encountered in the mediastinum; secondly, . . . [Full Text of this Article]


Related Article

S100 release as an indicator of cerebral damage
Donald Whitaker
Ann. Thorac. Surg. 2001 71: 2085. [Extract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The Society of Thoracic Surgeons.